Academic clinical fellowships in Trauma and Orthopaedics
The academic clinical fellowship programme in Trauma and orthopaedics is hosted by the Academic Unit of Bone Metabolism, located within the Department of Oncology and Metabolism.
Academic Unit of Bone Metabolism
The department hosts the Mellanby Centre for Bone Research and ARUK/MRS Centre for Integrated Research into Musculoskeletal Aging. The Mellanby Centre for Bone Research, based in the University of Sheffield’s Medical School, was established in 2009 and aims to establish a focus for bone research at the University of Sheffield, foster the development of inter-disciplinary research across the University, develop collaborative research programmes and grant applications, develop links with the pharmaceutical and biotechnology industry, and widen the profile of bone research at the University. We have a world-class translational programme of basic and clinical bone research with a wide-ranging and comprehensive remit.
This makes the Mellanby Centre for Bone Research unique in the UK, and one of only a small number of such institutes worldwide. The CIMA is a collaboration between researchers and clinicians at the Universities of Liverpool, Sheffield and Newcastle. Established in 2012, CIMA aims to understand why our bone, joints and muscles function less well as we age, and why older people develop clinical diseases of these musculoskeletal tissues, such as arthritis or osteoporosis.
Basic biomedical research within the department covers all aspects of bone cell biology and is supported by two dedicated core laboratories for bone research and bone analysis. The laboratories contain the latest automated immunoassay analysers, state of the art high resolution microCT imaging equipment, and the equipment and expertise necessary to undertake quantitative dynamic bone histomorphometry.
The ACF Programme
The ACF programme is directed by Mark Wilkinson, Professor of Orthopaedics Areas of research you may participate in will include osteoarthritis and inflammatory arthritis, patient responses to implant materials, and outcomes after joint replacement surgery. We utilise many approaches to study these diseases, including epidemiological studies, genetics, epigenetics, imaging, cytokines and biochemical markers. Our approaches to the study of these diseases include both clinical and pre-clinical and in-vitro models. Our research training programme of work is supported by the infrastructure available within the Department of Human Metabolism, the Mellanby Centre, and through close working with other Departments within the University, including the Faculty of Engineering, and through strong collaborations with colleagues at external institutions.
Academic Programme Director: Prof Mark Wilkinson email@example.com